von willebrand disease vwd common hereditary bloodclotting disorder humans acquired form sometimes result medical arises deficiency quality quantity von willebrand factor vwf multimeric protein required platelet adhesion known affect several breeds dogs well humans three forms vwd hereditary acquired pseudo platelet type three types hereditary vwd vwd type vwd type vwd type type contains various platelet type vwd also inherited new diagnostic category low vwf proposed include individuals whose von willebrand factor levels normal reference range low enough von willebrand disease levels iudl patients low vwf experience bleeding despite mild reductions vwf vwd type common type disorder mild bleeding symptoms nosebleeds though occasionally severe symptoms occur blood type affect presentation severity symptoms vwd type second common type disorder mild moderate symptoms factor named finnish physician erik adolf von willebrand first described condition guidelines diagnosis management vwd updated various types vwd present varying degrees bleeding tendency usually form easy bruising nosebleeds bleeding gumsmedical citation needed women may experience heavy menstrual periods blood loss severe internal bleeding bleeding joints uncommon severe type vwd type vwf gene located short arm p chromosome exons spanning types inherited autosomal dominant traits occasionally type also inherits recessively type inherited autosomal recessive however individuals heterozygous type may diagnosed vwd type indicating intermediate inheritance cases vwd occurs approximately population affects men women genetic testing typically part initial workup von willebrand disease needed people diagnosed type vwd based clinical history laboratory mainly useful von willebrand factor mainly active conditions high blood flow shear stress deficiency vwf therefore shows primarily organs extensive small vessels skin gastrointestinal tract uterus angiodysplasia form telangiectasia colon shear stress much higher average capillaries risk bleeding increased concomitantlymedical citation needed severe cases type vwd genetic changes common within vwf gene highly penetrant milder cases type vwd complex spectrum molecular pathology may exist addition polymorphisms vwf gene individuals abo blood group influence presentation pathology vwd individuals blood group lower mean level individuals blood groups unless abo groupspecific vwfantigen reference ranges used normal group individuals diagnosed type vwd individuals blood group ab genetic defect vwf may diagnosis overlooked vwf levels elevated due blood basic tests performed patient bleeding problems complete blood countcbc especially platelet counts activated partial thromboplastin timeaptt prothrombin time international normalized ratioptinr thrombin timett fibrinogen level patients abnormal tests typically undergo testing hemophilias coagulation factor assays may performed depending results coagulation screen patients von willebrand disease typically display normal prothrombin time variable prolongation partial thromboplastin timecitation needed vwd suspected blood plasma patient must investigated quantitative qualitative deficiencies vwf achieved measuring amount vwf vwf antigen assay functionality vwf glycoprotein gpib binding assay collagen binding assay ristocetin cofactor activity ricof ristocetininduced platelet agglutination ripa assays factor viii levels also performed factor viii bound vwf protects factor viii rapid breakdown within blood deficiency vwf lead reduction factor viii levels explains elevation ptt normal levels exclude forms vwd particularly type may revealed investigating platelet interaction subendothelium flow highly specialized coagulation study routinely performed medical laboratories platelet aggregation assay show abnormal response ristocetin normal responses agonists used platelet function assay may give abnormal collagenepinephrine closure time cases normal collagenadp time type may considered factor viii levels disproportionately low confirmation requires factor viii binding assay additional laboratory tests help classify subtypes vwd include von willebrand multimer analysis modified ristocetin induced platelet aggregation assay vwf propeptide vwf propeptide antigen ratio cases suspected acquired von willebrand syndrome mixing study analysis patient plasma along pooled normal plasmapnp mixture two tested immediately one hour two hours detection vwd complicated vwf acutephase reactant levels rising infection pregnancy stress testing vwd influenced laboratory procedures numerous variables exist testing procedure may affect validity test results may result missed erroneous diagnosis chance procedural errors typically greatest preanalytical phase collecting storage transportation specimen especially testing contracted outside facility specimen frozen transported long diagnostic errors uncommon rate testing proficiency varies amongst laboratories error rates ranging studies high cases misclassification vwd subtype increase probability proper diagnosis testing done facility immediate onsite processing specialized coagulation four hereditary types vwd described type type type pseudo platelettype cases hereditary acquired forms vwd described international society thrombosis haemostasiss classification depends definition qualitative quantitative type vwd vwd cases quantitative defect heterozygous defective gene arise failure secrete vwf circulation vwf cleared quickly normal decreased levels vwf detected normal ie many patients asymptomatic may mild symptoms clearly impaired clotting might suggest bleeding disorder often discovery vwd occurs incidentally medical procedures requiring blood workup cases type vwd never diagnosed due asymptomatic mild presentation type people usually end leading normal life free complications many unaware disorder trouble may however arise patients form bleeding following surgery including dental procedures noticeable easy bruising menorrhagia heavy menstrual periods minority cases type may present severe hemorrhagic symptoms type vwd cases qualitative defect bleeding tendency vary individuals four subtypes exist subtypes depend presence behavior underlying ability qualitatively defective von willebrand factors coalesce form large vwf multimers impaired resulting decreased quantity large vwf multimers low rcof activity small multimer units detected circulation von willebrand factor antigen vwfag assay low normal gain function defect ability qualitatively defective vwf bind glycoprotein ib gpib receptor platelet membrane abnormally enhanced leading spontaneous binding platelets subsequent rapid clearance bound platelets large vwf multimers thrombocytopenia may occur large vwf multimers reduced absent circulation ristocetin cofactor activity low patients plateletpoor plasma assayed formalinfixed normal donor platelets however assay performed patients platelets plateletrich plasma lowerthannormal amount ristocetin causes aggregation occur due large vwf multimers remaining bound patients platelets patients subtype unable use desmopressin treatment bleeding lead unwanted platelet aggregation aggravation thrombocytopenia type vwd qualitative defect vwf characterized decreased ability bind gpib receptor platelet membrane normal capability multimerization vwf antigen levels normal ristocetin cofactor activity decreased high molecular weight large vwf multimers present deficiency binding vwf coagulation factor viii vwf antigen test normal indicating normal quantity vwf ristocetin cofactor assay normal assay coagulation factor viii show marked quantitative decrease equivalent levels seen hemophilia led vwd type patients misdiagnosed hemophilia type severe form vwd homozygous defective gene characterized complete absence production vwf von willebrand factor undetectable vwf antigen assay since vwf protects coagulation factor viii proteolytic degradation total absence vwf leads extremely low factor viii level equivalent seen severe hemophilia clinical manifestations lifethreatening external internal hemorrhages inheritance pattern vwd type autosomal recessive inheritance pattern hemophilia xlinked recessive platelettype vwd also known pseudovwd autosomal dominant genetic defect platelets vwf qualitatively normal genetic testing von willebrand gene vwf protein reveals mutational alteration defect lies qualitatively altered gpib receptor platelet membrane increases affinity bind vwf large platelet aggregates high molecular weight vwf multimers removed circulation resulting thrombocytopenia diminished absent large vwf multimers ristocetin cofactor activity loss large vwf multimers similar vwd type acquired vwd occur patients autoantibodies case function vwf inhibited vwfantibody complex rapidly cleared circulationmedical citation needed form vwd occurs patients aortic valve stenosis leading gastrointestinal bleeding heydes syndrome form acquired vwd may prevalent presently thought vincentelli et al noted patients acquired vwd aortic stenosis underwent valve replacement experienced correction hemostatic abnormalities hemostatic abnormalities recur months prosthetic valve poor match similarly acquired vwd contributes bleeding tendency people implant left ventricular assist device pump pumps blood left ventricle heart patients vwd type vwd type desmopressin available different preparations recommended use cases minor trauma preparation dental minor surgical procedures desmopressin stimulates release vwf bodies endothelial cells thereby increasing levels vwf well coagulant factor viii three fivefold desmopressin also available preparation intranasal administration stimate preparation intravenous administration desmopressin contraindicated vwd type risk aggravated thrombocytopenia thrombotic complications desmopressin probably effective vwd type rarely effective vwd type totally ineffective vwd type citation needed women heavy menstrual bleeding estrogencontaining oral contraceptive medications effective reducing frequency duration menstrual periods estrogen progesterone compounds available use correction menorrhagia ethinylestradiol levonorgestrel levona nordette lutera trivora administration ethinylestradiol diminishes secretion luteinizing hormone folliclestimulating hormone pituitary leading stabilization endometrial surface uterusmedical citation needed desmopressin synthetic analog natural antidiuretic hormone vasopressin overuse lead water retention dilutional hyponatremia consequent convulsionmedical citation needed patients vwd scheduled surgery cases vwd disease complicated clinically significant hemorrhage humanderived medium purity factor viii concentrates also contain von willebrand factors available prophylaxis treatment humate p alphanate wilate koate hp commercially available prophylaxis treatment vwd monoclonally purified factor viii concentrates recombinant factor viii concentrates contain insignificant quantity vwf clinically usefulmedical citation needed development alloantibodies occurs patients receiving humanderived mediumpurity factor viii concentrates risk allergic reactions including anaphylaxis must considered administering preparations administration latter also associated increased risk venous thromboembolic complicationsmedical citation needed blood transfusions given needed correct anemia hypotension secondary hypovolemia infusion platelet concentrates recommended correction hemorrhage associated platelettype vwdmedical citation needed vonicog alfa recombinant von willebrand factor approved use united states december use european union august prevalence vwd one however majority people symptoms prevalence clinically significant cases one per forms rather mild detected often women whose bleeding tendency shows menstruation may severe apparent people blood type girl föglö åland finland brought deaconess hospital helsinki seen finnish physician erik adolf von willebrand ultimately assessed members family reported swedishlanguage article previously undescribed bleeding disorder differed published another article disorder german language attracted international attention eponymous name assigned disease late early recognition von willebrands extensive became clear plasma factor factor viii decreased persons cohn fraction could correct plasma deficiency fviii prolonged bleeding time since time factor causing long bleeding time called von willebrand factor honor erik adolf von willebrand variant forms vwf recognized variations recognized result synthesis abnormal protein molecular cellular studies distinguished hemophilia vwd precisely persons vwd normal fviii gene x chromosome abnormal vwf gene chromosome gene sequencing identified many persons vwf gene mutation genetic causes milder forms low vwf still investigation forms may always caused abnormal vwf gene vwd also affect dogs pigs mice furthermore cases reported cats horses cattle rabbits causal mutation vwd type identified dogs breeds doberman pinscher german pinscher bernese mountain dog manchester terrier kerry blue terrier cardigan welsh corgi poodle coton de tulear drentse patrijshond papillon stabyhoun causal mutations type identified dogs breeds german wirehaired pointer german shorthaired pointer chinese crested type dogs breeds kooikerhondje scottish terrier shetland sheepdog dogs affected type vwd causal mutation across breeds mutation also detected human vwd type patients contrast mutations causing vwd type dogs specific breed genetic screening offered known pigs causal mutation vwd type also identified large duplication within vwf gene causes serious damage gene function virtually vwf protein produced clinical picture pigs similar humans vwd type therefore pigs valuable models clinical pharmacological mice affected vwd type produced genetic engineering obtain small sized model human disease strains vwf gene knocked animals species affected vwd causal mutations yet identified case severe deficiency may spontaneous gingival bleeding ecchymosis epistaxis symptoms vwd include postoperative bleeding bleeding dental extraction gingival bleeding epistaxis easy bruising intake oral contraceptives firstline treatment menorrhagia may lead gingival enlargement bleeding platelet coagulation disorders severely altered hemostasis cause spontaneous gingival bleeding seen conjunction hyperplastic hyperemic gingival enlargements leukemic patients deposition hemosiderin blood degradation products tooth surfaces turning brown occur continuous oral bleeding long location oral bleeds follows labial frenum tongue buccal mucosa gingiva palate severe hemophilia frequent bleeding occurrences followed moderate mild hemophilia mostly come traumatic injuries bleeding also induced iatrogenic factors poor oral hygiene practices frequency oral hemorrhage location people deficiency f viii f ix gingiva dental pulp tongue lip palate buccal mucosa protocols suggest use factor concentrate along use local hemostatic techniques suturing local measures use oxidized cellulose example surgicel fibrin glue conjunction postoperatively administered antifibrinolytic agents use nonsteroidal antiinflammatory drug nsaid must discussed beforehand patients hematologist effect platelet aggregation restrictions regarding type local anaesthetic agent used although vasoconstrictors may provide additional local httpsenwikipediaorgwikivonwillebranddisease